Atlas Trials

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Clinical trial NCT04004234 · UNKNOWN

Trial details

NCT number
NCT04004234
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Biliary Tract Cancer (BTC)
Start date
2019-03-01
Primary completion
2020-08-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.